相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of VU6028418: A Highly Selective and Orally Bioavailable M4 Muscarinic Acetylcholine Receptor Antagonist
Matthew Spock et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy
Mark S. Moehle et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Discovery of BMS-986144, a Third-Generation, Pan-Genotype NS3/4A Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
Li-Qiang Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres
Qingyi Yang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders
Mark S. Moehle et al.
MOVEMENT DISORDERS (2019)
Crystal structure of the M5 muscarinic acetylcholine receptor
Ziva Vuckovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Structure-guided development of selective M3 muscarinic acetylcholine receptor antagonists
Hongtao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Discovery of 4-Azaindole Inhibitors of TGFβRI as Immuno-oncology Agents
Yong Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Applications of Palladium-Catalyzed C-N Cross-Coupling Reactions
Paula Ruiz-Castillo et al.
CHEMICAL REVIEWS (2016)
Characterization of PCS1055, a novel muscarinic M4 receptor antagonist
Carrie H. Croy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors
Mark Zak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release
Daniel J. Foster et al.
NEURON (2016)
Discovery of Spirofused Piperazine and Diazepane Amides as Selective Histamine-3 Antagonists with in Vivo Efficacy in a Mouse Model of Cognition
Dean G. Brown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Muscarinic acetylcholine receptors: novel opportunities for drug development
Andrew C. Kruse et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Evaluation of a 3-amino-8-azabicyclo[3.2.1]octane replacement in the CCR5 antagonist maraviroc
Remy C. Lemoine et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
分享论文
